首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   48691篇
  免费   3661篇
  国内免费   2464篇
耳鼻咽喉   254篇
儿科学   1358篇
妇产科学   472篇
基础医学   11228篇
口腔科学   387篇
临床医学   3658篇
内科学   13528篇
皮肤病学   578篇
神经病学   1215篇
特种医学   620篇
外国民族医学   7篇
外科学   2106篇
综合类   6294篇
现状与发展   18篇
预防医学   7317篇
眼科学   385篇
药学   2466篇
  13篇
中国医学   852篇
肿瘤学   2060篇
  2024年   47篇
  2023年   606篇
  2022年   1859篇
  2021年   2146篇
  2020年   1693篇
  2019年   1477篇
  2018年   1492篇
  2017年   1466篇
  2016年   1731篇
  2015年   2032篇
  2014年   2819篇
  2013年   2990篇
  2012年   2756篇
  2011年   3235篇
  2010年   2684篇
  2009年   2437篇
  2008年   2391篇
  2007年   2527篇
  2006年   2266篇
  2005年   1997篇
  2004年   1761篇
  2003年   1534篇
  2002年   1222篇
  2001年   1185篇
  2000年   961篇
  1999年   861篇
  1998年   754篇
  1997年   770篇
  1996年   627篇
  1995年   631篇
  1994年   594篇
  1993年   473篇
  1992年   354篇
  1991年   302篇
  1990年   269篇
  1989年   244篇
  1988年   231篇
  1987年   167篇
  1986年   142篇
  1985年   287篇
  1984年   180篇
  1983年   134篇
  1982年   120篇
  1981年   98篇
  1980年   68篇
  1979年   58篇
  1978年   51篇
  1977年   31篇
  1976年   31篇
  1975年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
为探讨孕妇乙型肝炎病毒(HBV)感染和某些因素对先天性畸形的致病作用,本文进行了96对新生儿先天畸形的配对(1:1)病例对照研究,报道先天畸形的频率和构成,单因素和多因素的条件Logistic回归分析,表明孕妇HBsAg阳性等6个因素对先天畸形呈阴性结果,而与接触农药和孕周的因素有明显联系,值得进一步探讨。  相似文献   
92.
Abstract Human immunodeficiency virus (HIV)-l neuropathogenesis can be divided into three important components: (i) virus entry into the nervous system; (ii) the role of viral proteins and/or cellular products in neural tissue damage; and (iii) the mechanisms of neuronal injury/death. Both blood derived macrophages or trafficking HIV-1 infected T-lymphocytes have been implicated in viral entry to the central nervous system (CNS). The major cell type harboring productive HIV-1 infection in the nervous system is the perivascular macrophage/ microglia. The HIV-1 infection of brain astrocytes, restricted to the expression of regulatory gene products, may cause astrocyte dysfunction and contribute to neuronal injury or to disruption of the blood-brain barrier (BBB). Studies of cerebrospinal fluid and postmortem tissues reveal chronic inflammation/immune activation in the nervous system during the later stages of HIV-1 infection associated with disruption of BBB integrity. Blood-brain barrier damage may underlie the white matter pallor described in HIV-1 infection and could result in further entry into the CNS of toxic viral or cellular products, or additional HIV-1 infected cells. The HIV infected and activated macrophages/microglia produce excessive amounts of pro-inflammatory cytokines, including tumor necrosis factor alpha, and platelet activating factor. These products are directly toxic to human neurons in vitro. The HIV-1 envelope glycoprotein, gp 120 may stimulate the release of toxic factors from brain macrophages. Blocking N-methyl-D-aspartate (NMDA; or AMPA) glutamate receptors can antagonize candidate toxins of both viral and cellular origin. It has been postulated that (weak) excitotoxicity leads to oxidative stress in neurons and ultimately to apoptosis. Neuronal apoptosis occurs in the brains of both children and adults with HIV-1 infection. This understanding of HIV neuropathogenesis implies that therapeutic strategies should include: (i) anti-retroviral medications to decrease systemic and CNS virus load, and possibly to prevent perinatal transmission of HIV; (ii) anti-inflammatory compounds to decrease the chronic immune activation in microglia and allow the restoration of BBB integrity; and (iii) neuroprotective compounds to reduce neuronal injury and apoptotic death.  相似文献   
93.
The clinical findings in 26 patients in whom hepatocellular carcinoma (HCC) was detected after the start of interferon (IFN) therapy for chronic hepatitis C were analysed. Histological study before IFN therapy showed that 34.6% of patients were categorized as stage 3 (septal fibrosis with architectural distortion; the 0–4 scale) and 80.8% demonstrated at least some evidence of septal fibrosis or more advanced features. The AFP levels examined before IFN therapy were more than 20 ng/mL in 13 patients (84.6% of those studied). One of 26 patients had a complete response to IFN therapy, while six of 26 patients had only a partial response. HCC was detected within 1 year after the start of IFN therapy in 76.9% of patients. Thus, the possibility of the early occurrence of HCC or its existence at the time of therapy should be seriously considered when IFN therapy is contemplated. Patients with stage 3 or 3–4 histology may already have a small undetectable HCC before IFN therapy. Thus, for this reason, every patient treated with IFN should be examined at short regular intervals for the development of HCC during and after IFN therapy.  相似文献   
94.
110例嗜酸细胞增多性非变应性鼻炎的液氮冷冻治疗山西医学院第二附属医院(030001)牛玉梅,刘学仁按Mggind将常年性鼻炎分为三类:一类常年性变态反应性鼻炎;二类非变态反应性鼻炎伴鼻分泌物嗜酸细胞增多综合征也叫嗜酸细胞增多性非变态反应性鼻炎(Eosinophilicnonalleraicrhinits,ENR);三类自主神经性常年性鼻炎[1]。我们将ENR中找不到致敏物,而与冷热空气有关与情绪无关的110例患者进行了液氮冷冻治疗。临床资料802例常年性鼻炎患者进行皮肤激发试验。437例找出了致敏物,进行特异性过敏诱因脱敏治疗或抗过敏药物治疗。365例试验阳性,其中有135例与冷热空气有关。ll0例行冷冻治疗。1l0例中男50例,女60例;年龄最大65岁,最小16岁。110例均有间歇性的连续喷嚏发作,浆液性或粘液性鼻分泌物增多和鼻粘膜非充血性肿胀引起的堵塞,无因吸入致敏原诱发症状的病史;血清IgE值不升高,特异性皮肤试验结果为阳性;鼻分泌物中嗜酸细胞阳性。方法:先将鼻腔内喷入1%地卡因溶液3次粘膜表面麻醉,用卷好的4厘米长、0.4~0.6厘米粗的棉棒沾上液氮在鼻镜直视下迅速插入鼻腔内。时间约1分钟左右(冷  相似文献   
95.
目的:通过研究丙型肝炎病毒高变区1(HCV HVR1)准种复杂性与基因型之间的关系,探讨不同基因型HCV致病性差异的机制.方法:采用C区型特异性引物PCR法进行HCV基因分型,采用单链构象多态性聚合酶链反应法(SSCP法)检测HCV HVR1准种.结果:68例丙型肝炎患者中,Ⅱ型49例(72%),Ⅲ型13例(19%),Ⅱ、Ⅲ混合型6例(9%).Ⅱ型和Ⅱ、Ⅲ混合型HCV感染患者的HCV HVR1准种复杂性(SSCP条带数)明显高于Ⅲ型感染的患者,且与疾病严重程度关系密切.结论:HCV HVR1准种复杂性的差异可能是导致不同基因型HCV致病性差异的因素之一.  相似文献   
96.
抗戊型肝炎病毒重组蛋白单克隆抗体的制备和初步应用   总被引:4,自引:0,他引:4  
目的:制备抗-戊型肝炎病毒的单克隆抗体,并将其用于分析戊型肝炎病毒不同毒株结构蛋白的抗原表位。方法:采用来自墨西哥株(Mexicanstrain)的戊型肝炎病毒重组蛋白(p166Mex)免疫Balb/c小鼠,取其脾细胞与SP2/0骨髓瘤细胞进行融合,经酶联免疫吸附试验(ELISA)法筛选阳性克隆,并将获得的单克隆抗体与戊型肝炎病毒缅甸株(Burmastrain)和美国株(USAstrain)的重组蛋白(p166Bur、p166US)进行交叉反应测定。结果:最终获得4株能稳定分泌抗-p166Mex的杂交瘤细胞株,即D8G10、E5E12、D4A3、B7E6。其中D8G10,E5E12和B7E6细胞株的培养上清液,还能分别与p166Bur和p166US重组蛋白发生阳性反应。结论:利用已获得的抗-p166Mex单克隆抗体,初步确定3种不同的戊型肝炎病毒重组蛋白(p166Bur、p166US、p166Mex)含有一种共同的抗原表位。  相似文献   
97.
湖南省乙肝病毒基因型分布及临床意义   总被引:1,自引:0,他引:1  
目的 :研究湖南省乙肝病毒 (HBV)基因型分布及临床意义。方法 :选择湖南省HBVDNA阳性慢性乙肝病人共 185例 ,其中病毒携带者 (ASC) 4 2例 ,慢性轻、中度肝炎 (CH) 38例 ,重型肝炎 (FHF) 80例 (伴有肝硬化者 4 9例 ) ,肝细胞癌 (HCC) 2 5例 ,采用聚合酶链反应 限制性片段长度多态性 (PCR RFLP)方法检测HBV基因型。结果 :基因型B136例 (73.5 % ) ,基因型C 4 9例 (2 6 .5 % )。基因型B在FHF中占绝对优势 (83.7% ) ,其次为HCC(76 % ) ,与ASC(5 7.1% )比较 ,差异有显著性 (P <0 .0 1)。与基因型B相比 ,基因型C在垂直传播感染者中多见 (38.8%与 13.2 % ,P <0 .0 0 1) ;HBeAg阳性率明显增高 (5 7.1%与 30 .9% ,P <0 .0 0 1) ;抗HBe阳性率明显下降 (36 .9%与 6 6 .2 % ,P <0 .0 0 1)。与基因型C相比 ,基因型B感染者ALT水平明显增高 (2 6 4 .5± 2 5 6 .5与 10 0± 12 0 .6 ,P <0 .0 0 1)。结论 :湖南省存在乙肝病毒基因型B和基因型C ;基因型B为优势基因型并与肝脏疾病活动性相关 ,基因型C与母婴垂直传播感染有关  相似文献   
98.
Antibodies against nerve growth factor (NGF) in sera were detected by enzyme-linked immunosorbent assays (ELISA), by their isolation after passage of sera through NGF immunoadsorbent columns and by their specificity to bind and immunoprecipitate mouse NGF as well as to stain by immunohistochemical methods cellular sites of NGF synthesis. Increased levels of anti-NGF antibodies were found in sera of herpes simplex virus (HSV)-infected patients but not in HSV-inoculated rabbits. As HSV latency is known to be promoted by NGF in vitro, these results may suggest that anti-NGF antibodies modulate the cytokine function of NGF and thus might play a role in HSV infection. The biological function of circulating antibodies against NGF, in general, is now open to future investigation.  相似文献   
99.
本文通过免疫荧光(IF)和电镜(EM)技术对新疆出血热(XHF)及流行性出血热(EHF)病毒的生物学特性在Vero E_6及LLC-MK_2两株传代细胞上进行了比较。两种病毒感染两株细胞后免疫荧光染色有两种不同的荧光形态特征,两种病毒对细胞的敏感性明显不同,XHF病毒在LLC-MK_2细胞上感染后6~8天可出现明显的细胞病变,而EHF病毒感染此细胞后则不引起病变。电镜观察到两种病毒在LLC-MK_2细胞中都能形成与布尼病毒相似的形态特征。  相似文献   
100.
Different doses of hepatitis B virus vaccine—prepared by Korea Green Cross Corporation, were given to healthy infants born to HBsAg-negative mothers at birth, 1 and 6 months of age. A dose of 2 μg was administered intradermally in Group A and, in the three other groups, the vaccine was given intramuscularly (i.m.). An adequate follow-up observation was possible for 9 months after birth in 22, 25, 23 and 21 infants in Groups A, B, C and D, respecvely.
Group C (5 μg, i.m.) produced seroconversion most rapidly, showing the highest rate (96%) at 9 months of age. The lowest seroconversion rate (5%) was found at the age of 1 month in Group A subjects, but the rate increased to 91% after a booster dose was given at 6 months of age.
While it can be concluded that a 5 μg i.m. dose of vaccine at 0, 1 and 6 months of age is optimum for the immunization of infants in efficacy and economy, a 2 μg intradermal dose can also be considered as an immunogenic and economical regimen, though the immune response is slower and a special technique is required for immunization.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号